FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sumatriptan Nasal Spray
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Prasco Laboratories (New 09/08/2025)

Company Contact Information:
866-525-0688

Presentation	Posting Date	Related Information
Imitrex, Nasal Spray, 5 mg/100 uL (NDC 66993-081-69)	09/08/2025	This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately February 28, 2026.
Imitrex, Nasal Spray, 20 mg/100 uL (NDC 66993-082-69)	09/08/2025	This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately March 16, 2026.